In a landmark achievement for transplant surgery and the management of end-stage cystic fibrosis (CF), surgeons at UChicago Medicine have successfully performed a quadruple-organ transplant on 28-year-old Jasmine Jones. The complex, 36-hour operation—which involved the replacement of both lungs, the liver, and a kidney from a single donor—represents the first procedure of its kind in Illinois and only the sixth in the history of the United States, according to data from the United Network for Organ Sharing (UNOS).
This medical feat underscores the evolving capabilities of modern surgical teams to treat systemic diseases that previously presented as insurmountable obstacles to life-saving interventions.
The Clinical Challenge: Why Four Organs?
Cystic fibrosis is a genetic condition that causes the body to produce thick, sticky mucus that clogs the lungs and obstructs the pancreas. While advancements in CFTR modulators have transformed the lives of many patients, the disease remains a multisystem threat.
For Jasmine Jones, the progression of the disease was relentless. Diagnosed as an infant, she lived a relatively typical life until her late teens, when the cumulative damage of the disease began to manifest in severe, systemic ways. The excess mucus characteristic of CF did not merely affect her respiratory system; it created a domino effect of organ failure.
In CF patients, the liver is particularly vulnerable because the bile ducts become obstructed by thickened secretions, leading to irreversible scarring and cirrhosis. As Jones’s condition deteriorated, she developed CF-related diabetes and end-stage liver and kidney failure. While a lung transplant is a recognized intervention for advanced CF, the necessity for a multi-organ transplant introduced a terrifying clinical paradox: how to perform a transplant on a patient whose body was harboring drug-resistant bacteria in her lungs, while simultaneously suppressing the immune system to prevent organ rejection.
Chronology of the Procedure
The operation, which took place beginning January 5, 2026, required a meticulous, multi-stage approach. The surgical team had to carefully sequence the organ replacements to minimize the risks of infection and ensure the hemodynamic stability of the patient.
Phase 1: The Pulmonary Intervention
The procedure began with the removal of Jones’s diseased lungs and the transplantation of new, healthy donor lungs. This was not merely a curative step for her respiratory failure, but a strategic move. According to Dr. Pablo Sanchez, a thoracic surgeon at UChicago Medicine, the removal of the original lungs was essential to eliminate the reservoir of drug-resistant bacteria that would have inevitably caused a lethal infection once the patient’s immune system was suppressed by anti-rejection medications.
Phase 2: Hepatic and Renal Replacement
Following the lung transplant, the team transitioned to the liver. A critical component of this stage was the use of specialized organ-preservation technology—a device that continuously pumped oxygen-rich blood through the donor liver to ensure its viability and minimize "ischemia-reperfusion" injury, a common complication in major organ transfers.
Phase 3: Post-Operative Stabilization and Kidney Transplant
Following the successful implantation of the liver, Jones was moved to the intensive care unit (ICU) for a period of 24 hours. This stabilization period was vital to allow her body to adjust to the new pulmonary and hepatic systems. On the second day, surgeons proceeded with the final stage: the transplantation of the donor kidney.
Supporting Data and Medical Context
The success of this operation was not an isolated stroke of luck, but the culmination of years of institutional expertise. The UChicago Medicine Transplant Institute holds the distinction of having performed more triple-organ transplants than any other center in the world.
Understanding the "Quadruple" Complexity
Transplant surgery is fraught with the risk of organ rejection, where the recipient’s immune system identifies the new organs as foreign invaders. In a single-organ transplant, immunosuppression protocols are standard. However, in a quadruple transplant, the risk of systemic infection is magnified exponentially. By removing the source of the chronic infection—the lungs—the surgeons effectively "reset" the patient’s biological environment, providing the new liver and kidney a safer environment in which to thrive.
The Role of Donor Coordination
A quadruple-organ transplant requires a singular, perfectly matched donor to ensure compatibility across all four organs. The UNOS system played a pivotal role in coordinating the logistics of the procurement. Because the organs were sourced from a single donor, the immunological profile of the tissues was consistent, which significantly lowered the risk of cross-organ rejection.
Official Responses and Medical Perspectives
The surgical team at UChicago Medicine emphasized that this operation was a victory of interdisciplinary cooperation.
"It’s second nature at UChicago Medicine to work in big teams and across medical specialties," noted Dr. Rolf Barth, transplant surgeon and co-director of the Transplant Institute. "The number of people involved in Jasmine’s case—from the initial work-up to the rigorous approval process and the surgery itself—represented an effort that even major centers specializing in complex cases often struggle to accomplish."
Dr. Edward Naureckas, the pulmonologist who directed Jones’s adult cystic fibrosis program, provided the scientific context regarding the liver failure. "The liver secretes bile through very small ducts," he explained. "In CF patients, these ducts get plugged up because the bile is simply too thick. Over time, this leads to structural damage that no medication can reverse."
Dr. Ashley Suah, who led the kidney and liver transplant efforts, praised the patient’s resilience. "Jasmine’s body had been through so much, but she handled every challenge with incredible fortitude," Suah stated. "She was the ideal candidate because she possessed the mental and physical stamina required to survive such an arduous recovery."
Implications for Future CF Treatment
The success of the Jones case has several profound implications for the future of cystic fibrosis care and transplant medicine:
- Validation of Aggressive Intervention: The case proves that even when CF presents with multi-organ failure, patients should not be considered "inoperable." It establishes a new roadmap for using organ removal as a prophylactic measure against post-operative sepsis in immunocompromised patients.
- Expanding the Definition of "Transplantable": As medical technology improves, the threshold for who qualifies for a transplant is shifting. The ability to manage a quadruple-organ recipient suggests that, with the right team, the most complex multisystem failures are potentially treatable.
- The Importance of Specialized Centers: The surgery highlights why patients with complex, rare complications should be referred to high-volume transplant centers. The logistical coordination required for a 36-hour surgery involving multiple specialized teams is not feasible in standard hospital settings.
Recovery and Looking Ahead
Jasmine Jones’s recovery journey was as rigorous as the surgery itself. She spent six weeks in the hospital followed by several weeks of intensive inpatient rehabilitation. As of early 2026, she is continuing her recovery in an outpatient setting.
Her current treatment plan focuses on strict adherence to immunosuppressant medications. Clinical monitoring has confirmed that her new organs are currently functioning perfectly and, crucially, are entirely free of cystic fibrosis. While she will require lifelong medical monitoring, the procedure has effectively granted her a second chance at life, free from the constraints of failing lungs, a cirrhotic liver, and renal insufficiency.
For the medical community, Jones’s case remains a beacon of what is possible when surgical precision, advanced organ-preservation technology, and a unified interdisciplinary team converge. As we look toward the future, this "quadruple-organ" milestone will likely serve as a foundational case study for the next generation of transplant surgeons.
